Future directions with platelet growth factors

Seminars in Hematology

Volumn 37, Issue 2 SUPPL. 4, 2000, Pages 41-49

  Kuter, David J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C MPL LIGAND; HYBRID PROTEIN; INTERLEUKIN 3; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT THROMBOPOIETIN; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGENICITY; APHERESIS; APOPTOSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIVER DISEASE; MOUSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RADIATION PROTECTION; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

EID: 0034085801     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0037-1963(00)90052-0     Document Type: Review

References (47)

1. RL Basser JE Rasko K Clarke Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer Blood 89 1997 3118 3128
2. RL Basser JE Rasko K Clarke Erratum Blood 90 1997 2513
3. M Fanucchi J Glaspy J Crawford Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer N Engl J Med 336 1997 404 409
4. S Vadhan-Raj Recombinant human thrombopoietin: Clinical experience and in vivo biology Semin Hematol 35 1998 261 268
5. S Vadhan-Raj C Verschraegen L McGarry Recombinant human thrombopoietin (rhTPO) attenuates high-dose carboplatin (C)-induced thrombocytopenia in patients with gynecologic malignancy Blood 90 suppl 1 1997 580a abstr 2581
6. S Vadhan-Raj LJ Murray C Bueso-Ramos Stimulation of megakaryocyte and platelet produc-tion by a single dose of recombinant human thrombopoietin in patients with cancer Ann Intern Med 126 1997 673 681
7. D Tomita M Petrarca T Paine Effect of a single dose of pegylated human recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet counts: Implication. for platelet apheresis Transfusion 37 suppl 9 1997 2S abstr S8
8. J Crawford J Glaspy C Belani A randomized, placebo-controlled, blinded, dose scheduling trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-RHUMGDF) with filgrastim support in non-small cell lung cancer (NSCLC) patients treated with paclitaxel and carboplatin during multiple cycles of chemotherapy Proc Am Soc Clin Oncol 17 1998 73a (abstr 285)
9. C Yang Y Xia J Li DJ Kuter The appearance of anti-thrombopoietin antibody and circulating thrombopoietin-IgC complexes in a patient developing thrombocytopenia after the injection of PRG-rHuMGDF Blood 94 suppl 1 1999 681a abstr 3014
10. J Li Y Xia A Bertino Characterization of an anti-thrombopoietin antibody that developed in a cancer patient following the injection of PRG-rHuMGDF Blood 94 suppl 1 1999 51a abstr 214
11. JG Giri WG Smith LE Kahn Promegapoietin, a chimeric growth factor for megakaryocyte and, platelet restoration Blood 90 suppl 1 1997 580a abstr 2583
12. SE Cwirla P Balasubramanian DJ Duffin Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine Science 276 1997 1696 1699
13. RL Basser JE Rasko K Clarke Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer Lancet 348 1996 1279 1281
14. JL Nichol Endogenous TPO (eTPO) level in health and disease: Possible clues for therapeutic intervention Stem Cells 16 suppl 2 1998 165 175
15. M Fontenay-Roupie JM Dupont Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia Leuk Res 22 1998 527 535
16. JA Adams JA Liu Yin ML Brereton The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia Br J Haematol 99 1997 139 146
17. DJ Kuter In vivo effects of Mpl ligand administration and emerging clinical applications for the Mpl ligands Curr Opin Hematol 4 1997 163 170
18. JL Nichol Thrombopoietin levels after chemotherapy and in naturally occurring human diseases Curr Opin Hematol 5 1998 203 208
19. LA Harker Kinetics of thrombopoiesis J Clin Invest 47 1968 458 465
20. LA Harker CA Finch Thrombokinetics in man J Clin Invest 48 1969 963 974
21. LA Harker Regulation of thrombopoiesis Am J Physiol 218 1970 1376 1380
22. PJ Ballem GM Segal JR Stratton Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: Evidence of both impaired platelet production and increased platelet clearance J Clin Invest 80 1987 33 40
23. PJ Ballem A Belzberg DV Devine Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection N Engl J Med 327 1992 1779 1784
24. N Suvajdzic Z Rolovic I Elezovic M Colovic Megakaryocytopoiesis in refractory chronic immune thrombocytopenia Hematol Cell Ther 41 1999 163 168
25. D Kuter J McCullough J Romo Treatment of platelet (PLT) donors with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increases circulating PLT counts (CTS) and PLT aphersis yields and increases platelet increments in recipients of PLT transfusions Blood 90 suppl 1 1997 abstr 2579
26. DJ Kuter The use of PEG-rHuMGDF in platelet apheresis Stem Cells (Dayt) 16 suppl 2 1998 231 242
27. LT Goodnough J DiPersio J McCullough Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increases platelet (plt) count (ct) and apheresis yields of normal plt donors: Initial results Transfusion 37 suppl 9 1997 67S abstr S266
28. RH Aster Pooling of platelets in the spleen: Role in the pathogenesis of “hypersplenic” thrombocytopenia J Clin Invest 45 1966 645 657
29. RH Aster Studies of the mechanism of “hypersplenic” thrombocytopenia in rats J Lab Clin Med 70 1967 736 751
30. FJ de Sauvage PE Hass SD Spencer Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand Nature 369 1994 533 538
31. S Nomura K Ogami K Kawamura Cellular localization of thrombopoietin mRNA in the liver by in situ hybridization Exp Hematol 25 1997 565 572
32. Y Shimada T Kato K Ogami Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines Exp Hematol 23 1995 1388 1396
33. NP Siemensma PS Bathal DG Penington The effect of massive liver resection on platelet kinetics in the rat J Lab Clin Med 86 1975 817 833
34. S Qian F Fu W Li Primary role of the liver in thrombopoietin production shown by tissue-specific knockout Blood 92 1998 2189 2191 (letter)
35. M Peck-Radosavljevic J Zacherl YG Meng Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27 1997 127 131
36. M Peck-Radosavljevic M Wichlas J Zacherl Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production Blood 95 2000 795 801
37. D Coleman D Fairchild J Schindler-Horvat Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression Toxicological Sciences 45 1998 77 87
38. LA Harker RA Carter UM Marzec Correction of thrombocytopenia and ineffective platelet production in patients infected with human immunodeficiency virus (HIV) by PEG-rHuMGDF therapy Blood 92 suppl 1 1998 707 abstr 2907
39. LA Harker UM Marzec F Novembre Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor Blood 91 1998 4427 4433
40. W Piacibello F Sanavio L Garetto Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood Blood 89 1997 2644 2653
41. W Piacibello F Sanavio MF Brizzi Megakaryocyte growth and development factor (MGDF)-induced acute leukemia cell proliferation and clonal growth is associated with functional c-mpl Leukemia 11 1997 531 540
42. M Yagi KA Ritchie E Sitnicka Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin Proc Nat Acad Sci USA 96 1999 8126 8131
43. KJ Neelis TP Visser W Dimjati A single dose of thrombopoietin shortly after myelosuppressive total body irradiation prevents pancytopenia in mice by promoting short-term multilineage spleen-repopulating cells at the transient expense of bone marrow—repopulating cells Blood 92 1998 1586 1597
44. K Kaushansky N Lin A Grossmann Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice Exp Hematol 24 1996 265 269
45. K Kaushansky Thrombopoietin: More than a lineage-specific megakaryocyte growth factor Stem Cells (Dayt) 15 suppl 1 1997 97 102
46. K Kaushansky Thrombopoietin and the hematopoietic stem cell Blood 92 1998 1 3
47. MA Mouthon A Van der Meeren MH Gaugler Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation Int J Radiat Oncol Biol Phys 43 1999 867 875